Cargando…

Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy

SARS-CoV-2 vaccinations were initially shown to substantially reduce risk of severe disease and death. However, pharmacokinetic (PK) waning and rapid viral evolution degrade neutralizing antibody (nAb) binding titers, causing loss of vaccinal protection. Additionally, there is inter-individual heter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoddard, Madison, Yuan, Lin, Sarkar, Sharanya, Mangalaganesh, Shruthi, Nolan, Ryan P., Bottino, Dean, Hather, Greg, Hochberg, Natasha S., White, Laura F., Chakravarty, Arijit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140995/ https://www.ncbi.nlm.nih.gov/pubmed/37112718 http://dx.doi.org/10.3390/vaccines11040806

Ejemplares similares

Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection
por: Bottino, Dean, et al.
Publicado: (2021)

Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2
por: Stoddard, Madison, et al.
Publicado: (2021)

In the long shadow of our best intentions: Model-based assessment of the consequences of school reopening during the COVID-19 pandemic
por: Johnson, Kaitlyn E., et al.
Publicado: (2021)

Individually optimal choices can be collectively disastrous in COVID-19 disease control
por: Stoddard, Madison, et al.
Publicado: (2021)

Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
por: Van Egeren, Debra, et al.
Publicado: (2023)

No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
por: Van Egeren, Debra, et al.
Publicado: (2022)

Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion
por: Albright, Catherine, et al.
Publicado: (2023)

Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic
por: Bayly, Henry, et al.
Publicado: (2023)

Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure
por: Van Egeren, Debra, et al.
Publicado: (2021)

Growth Rate Analysis and Efficient Experimental Design for Tumor Xenograft Studies
por: Hather, Gregory, et al.
Publicado: (2014)

Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis
por: Van Egeren, Debra, et al.
Publicado: (2021)

Detecting in-school transmission of SARS-CoV-2 from case ratios and documented clusters
por: Johnson, Kaitlyn E., et al.
Publicado: (2021)

Chagas Disease in HIV-Infected Patients: It’s Time to Consider the Diagnosis
por: Nolan, Melissa S., et al.
Publicado: (2021)

“But Mouse, You Are Not Alone”: On Some Severe Acute Respiratory Syndrome Coronavirus 2 Variants Infecting Mice
por: Kuiper, Michael J, et al.
Publicado: (2022)

Erratum to: “But Mouse, You Are Not Alone”: On Some Severe Acute Respiratory Syndrome Coronavirus 2 Variants Infecting Mice
por: Kuiper, Michael J, et al.
Publicado: (2022)

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?
por: Cazzola, Mario, et al.
Publicado: (2023)

Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
por: Van Egeren, Debra, et al.
Publicado: (2021)

Mutational signature assignment heterogeneity is widespread and can be addressed by ensemble approaches
por: Wu, Andy J, et al.
Publicado: (2023)

The role of schools in driving SARS-CoV-2 transmission: Not just an open-and-shut case
por: White, Laura F., et al.
Publicado: (2022)

Beyond the average patient: how neuroimaging models can address heterogeneity in dementia
por: Verdi, Serena, et al.
Publicado: (2021)

Addressing intra-tumoral heterogeneity and therapy resistance
por: Rybinski, Brad, et al.
Publicado: (2016)

Abstract of the Introductory Address Delivered at the Buffalo Medical College, Wednesday, Nov. 3d, 1875
por: Stoddard, E. V.
Publicado: (1875)

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Kalasekar, Sharanya Maanasi, et al.
Publicado: (2021)

Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
por: Galaznik, Aaron, et al.
Publicado: (2019)

Addressing cellular heterogeneity in tumor and circulation for refined prognostication
por: Lim, Su Bin, et al.
Publicado: (2019)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Addressing the heterogeneity in liver diseases using biological networks
por: Lam, Simon, et al.
Publicado: (2020)

Addressing Mental Health in Persons with IBD
por: Bernstein, Charles N
Publicado: (2018)

Variation in COVID-19 booster uptake in England: An ecological study
por: Dropkin, Greg
Publicado: (2022)

Data-driven approaches can harness crop diversity to address heterogeneous needs for breeding products
por: van Etten, Jacob, et al.
Publicado: (2023)

A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species
por: Bohning, Kelly, et al.
Publicado: (2021)

Procalcitonin-guided antibiotic usage - addressing heterogeneity in meta-analysis
por: Birajdar, Amit Ravindra, et al.
Publicado: (2018)

Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

The Role of Multigene Assays in Addressing Treatment Heterogeneity for Breast Cancer
por: Aapro, Matti
Publicado: (2017)

Cytotoxic Lesions of the Corpus Callosum (CLOCC) Suggesting Exacerbation by Heterogeneous COVID-19 Booster Vaccination
por: Chiba, Yuta, et al.
Publicado: (2023)

Booster
Publicado: (1997)

Effects of Dance Therapy on Balance and Risk of Falls in Older Persons
por: Chakravarty, Esha, et al.
Publicado: (2020)

Valedictory Address: "The Personal Factor in Maternal Mortality"
por: Nicholson, H. Oliphant
Publicado: (1936)

Conversion Booster Présentation Interface RF Booster
por: Arruat, M, et al.
Publicado: (1993)

Conversion Booster Présentation layout DSC Booster
por: Arruat, M, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_revf6l10oe3om042in8d2i2233